Abdul-Ghani, M. A., Puckett, C., Triplitt, C., Maggs, D., Adams, J., Cersosimo, E., & DeFronzo, R. A. (2015). Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): A randomized trial. Diabetes Obes Metab.

Abdul-Ghani, M. A., C. Puckett, C. Triplitt, D. Maggs, J. Adams, E. Cersosimo, and R. A. DeFronzo. "Initial Combination Therapy With Metformin, Pioglitazone and Exenatide Is More Effective Than Sequential Add-on Therapy in Subjects With New-onset Diabetes. Results From the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): A Randomized Trial." Diabetes Obes Metab 2015.

Abdul-Ghani, M. A., et al. "Initial Combination Therapy With Metformin, Pioglitazone and Exenatide Is More Effective Than Sequential Add-on Therapy in Subjects With New-onset Diabetes. Results From the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): A Randomized Trial." Diabetes Obes Metab 2015.